Approval · Notice of Compliance 10402 · 2009
LANOXIN: Notice of Compliance 10402
Issued July 20, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10402
- Date
- July 20, 2009
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New tablet formulation
- Therapeutic class
- Cardiotonic glycoside
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LANOXIN | Not yet assigned | — |